Biotricity (OTCMKTS:BTCY) Trading Down 4%

Biotricity, Inc. (OTCMKTS:BTCY)’s stock price fell 4% during trading on Monday . The company traded as low as $0.92 and last traded at $0.95. 10,404 shares were traded during trading, a decline of 73% from the average session volume of 38,058 shares. The stock had previously closed at $0.99.

Biotricity Stock Performance

The business has a fifty day simple moving average of $1.72 and a 200 day simple moving average of $2.75. The stock has a market cap of $8.14 million, a price-to-earnings ratio of -0.60 and a beta of 2.34.

Biotricity (OTCMKTS:BTCY) last announced its earnings results on Tuesday, November 14th. The company reported ($0.44) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.10). The business had revenue of $2.89 million during the quarter, compared to analysts’ expectations of $3.30 million. On average, equities research analysts anticipate that Biotricity, Inc. will post -1.43 EPS for the current fiscal year.

Institutional Investors Weigh In On Biotricity

A number of large investors have recently bought and sold shares of BTCY. State Street Corp boosted its holdings in shares of Biotricity by 586.8% during the first quarter. State Street Corp now owns 135,295 shares of the company’s stock worth $307,000 after purchasing an additional 115,595 shares during the last quarter. Beacon Pointe Advisors LLC acquired a new stake in shares of Biotricity during the first quarter worth $77,000. Jane Street Group LLC acquired a new stake in shares of Biotricity during the first quarter worth $27,000. Virtu Financial LLC acquired a new stake in shares of Biotricity during the first quarter worth $50,000. Finally, Strengthening Families & Communities LLC acquired a new stake in shares of Biotricity during the first quarter worth $135,000. Institutional investors and hedge funds own 32.46% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.